Brind.

Travere Therapeutics, Inc. presented abstracts at a congress held in Kyoto.

2 reports, 2 independent Updated Sep 3
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Travere Therapeutics, Inc. presented abstracts at a congress held in Kyoto.

Who's involved

What this event is mainly about
Kyoto

How it developed

Newest first. Tap a step to see who reported it.
  1. Cyclo Therapeutics, a subsidiary of Rafael Holdings, presented research on Trappsol Cyclo designed to impact NPC1 in Kyoto.Sub-event
  2. Travere Therapeutics presented abstracts at a congress in Kyoto.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Business WireTravere Therapeutics Presents Abstracts at the 15th International Congress of Inborn Errors of Metabolism Presentation details long-term safety and efficacy data on pegtibatinase as a potential treat
  • Simply Wall St.When Will Travere Therapeutics, Inc. (NASDAQ:TVTX) Become Profitable? Explore Travere Therapeutics's Fair Values from the Community and select yours We feel now is a pretty good time to analyse Trave